Skip to main content
Journal cover image

Medical and surgical treatment of placenta percreta to optimize bladder preservation.

Publication ,  Journal Article
Lee, PS; Bakelaar, R; Fitpatrick, CB; Ellestad, SC; Havrilesky, LJ; Alvarez Secord, A
Published in: Obstet Gynecol
August 2008

BACKGROUND: Placenta percreta is associated with significant morbidity and mortality. Interventions are dictated by hemodynamic stability, desire to retain future fertility, and efforts to reduce surgical morbidity at time of delivery. CASES: Two cases of antenatally diagnosed placenta percreta with bladder invasion are presented. Conservative management was used, including endovascular interventions, leaving the placenta in situ, methotrexate, and delayed hysterectomy. Postoperative outcomes were acceptable, with no significant hemorrhagic complications or need for extensive bladder reconstruction. CONCLUSION: Antenatal diagnosis of placenta percreta with bladder invasion is essential in the multidisciplinary management of this potentially catastrophic condition. A comprehensive approach including delayed hysterectomy after medical management resulted in an excellent clinical outcome.

Duke Scholars

Published In

Obstet Gynecol

DOI

ISSN

0029-7844

Publication Date

August 2008

Volume

112

Issue

2 Pt 2

Start / End Page

421 / 424

Location

United States

Related Subject Headings

  • Urinary Bladder Diseases
  • Pregnancy
  • Placenta Accreta
  • Obstetrics & Reproductive Medicine
  • Nucleic Acid Synthesis Inhibitors
  • Methotrexate
  • Hysterectomy
  • Humans
  • Female
  • Embolization, Therapeutic
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, P. S., Bakelaar, R., Fitpatrick, C. B., Ellestad, S. C., Havrilesky, L. J., & Alvarez Secord, A. (2008). Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol, 112(2 Pt 2), 421–424. https://doi.org/10.1097/AOG.0b013e31817e7966
Lee, Paula S., Ryan Bakelaar, C Brennan Fitpatrick, Sarah C. Ellestad, Laura J. Havrilesky, and Angeles Alvarez Secord. “Medical and surgical treatment of placenta percreta to optimize bladder preservation.Obstet Gynecol 112, no. 2 Pt 2 (August 2008): 421–24. https://doi.org/10.1097/AOG.0b013e31817e7966.
Lee PS, Bakelaar R, Fitpatrick CB, Ellestad SC, Havrilesky LJ, Alvarez Secord A. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol. 2008 Aug;112(2 Pt 2):421–4.
Lee, Paula S., et al. “Medical and surgical treatment of placenta percreta to optimize bladder preservation.Obstet Gynecol, vol. 112, no. 2 Pt 2, Aug. 2008, pp. 421–24. Pubmed, doi:10.1097/AOG.0b013e31817e7966.
Lee PS, Bakelaar R, Fitpatrick CB, Ellestad SC, Havrilesky LJ, Alvarez Secord A. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol. 2008 Aug;112(2 Pt 2):421–424.
Journal cover image

Published In

Obstet Gynecol

DOI

ISSN

0029-7844

Publication Date

August 2008

Volume

112

Issue

2 Pt 2

Start / End Page

421 / 424

Location

United States

Related Subject Headings

  • Urinary Bladder Diseases
  • Pregnancy
  • Placenta Accreta
  • Obstetrics & Reproductive Medicine
  • Nucleic Acid Synthesis Inhibitors
  • Methotrexate
  • Hysterectomy
  • Humans
  • Female
  • Embolization, Therapeutic